MVP 0.00% 47.0¢ medical developments international limited

Ann: Preliminary Final Report and Full Year Accounts, page-4

  1. 476 Posts.
    lightbulb Created with Sketch. 46
    MVP anticipates strong sales growth in FY22 driven by
    rapid development of our European commercial footprint
    and renewed vigour and focus locally to build on our strong
    profile in the Australian market. This is despite the ongoing
    challenges of COVID-19 in our key markets.
    We believe the changes in recent months have positioned
    MVP well for a period of strong international growth.
    We look forward to reporting further progress at our AGM
    scheduled for late October 2021
 
watchlist Created with Sketch. Add MVP (ASX) to my watchlist
(20min delay)
Last
47.0¢
Change
0.000(0.00%)
Mkt cap ! $40.56M
Open High Low Value Volume
47.0¢ 47.0¢ 46.5¢ $7.57K 16.18K

Buyers (Bids)

No. Vol. Price($)
1 101711 47.0¢
 

Sellers (Offers)

Price($) Vol. No.
47.5¢ 3018 1
View Market Depth
Last trade - 16.10pm 18/07/2024 (20 minute delay) ?
MVP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.